Comparative study of e-cigarette aerosol and cigarette smoke effect on ex vivo embryonic chick lung explants.
Nonclinical
Respiratory Toxicity
In Vitro
Silva-Ribeiro (2023)
Use of human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.
Nonclinical
Cardiovascular Toxicity
In Vitro
Simms (2022)
Baseline effects of non-flavored e-liquids in the in vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Smart (2019)
a comparative assessment of e-cigarette aerosol extracts and tobacco cigarette smoke extracts on in vitro endothelial cell inflammation response.
Nonclinical
Respiratory Toxicity
In Vitro
Su (2022)
The main e-cigarette component vegetable glycerin enhances neutrophil migration and fibrosis in endotoxin-induced lung injury via p38 MaPK activation.
Nonclinical
Respiratory Toxicity
In Vitro
Su (2023)
Electronic-Cigarette Vehicles and Flavoring affect Lung Function and Immune Responses in a Murine Model.
Nonclinical
Respiratory Toxicity
In Vitro
Szafran (2020)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part Two. In vitro micronucleus assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
Genotoxicity evaluation of tobacco and nicotine delivery products: Part One. Mouse lymphoma assay.
Nonclinical
Genotoxicity
In Vitro
Thorne (2019)
In Vitro Toxicological Investigation and Risk assessment of E-Cigarette aerosols Based on a Novel Solvent-Free Extraction Method.
Nonclinical
ALL
In Vitro
Wang (2022)
a comparative in vitro toxicity assessment of electronic vaping product e-liquids and aerosols with tobacco cigarette smoke.
Nonclinical
ALL
In Vitro
Wieczorek (2020)